Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01170208 · ClinicalTrials.gov registry record · NA
Insulin Dosage Software Program for People With Type 1 and Type 2 Diabetes
A NA study, sponsored by HealthPartners Institute.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT01170208 is a NA study that has completed, run by HealthPartners Institute. The registered enrollment target is 46 participants.
The verdict
NCT01170208, a NA study, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the effectiveness and safety of the computer software program in providing insulin dosage recommendations. Participation in the study for 60 research subjects will last for 16-weeks and includes 3-4 clinic visits and a series of weekly telephone calls from the study team (minimum of 12 calls). Participants will be provided with weekly Study Log Sheets to record their daily blood glucose readings, insulin doses, grams of carbohydrate eaten at each meal (if they have type-1 diabetes) and any changes in their health (e.g., hypoglycemic episodes, illnesses). Participants will fax or drop off a copy of the Study Log Sheet. This information will be entered by the IDC study team into the computer software program. The IDC study team will review the information from the software and, based on the IDC's study team approval, any insulin dose changes will be communicated back to the patient by phone or fax.
Interventions
- DEVICE insulin dose software
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01170208
The ClinicalTrials.gov registry entry for NCT01170208 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which insulin dose software is the first listed.
NCT01170208 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01170208 about?
NCT01170208 is a clinical study titled "Insulin Dosage Software Program for People With Type 1 and Type 2 Diabetes". The purpose of the study is to determine the effectiveness and safety of the computer software program in providing insulin dosage recommendations. Participation in the study for 60 research subjects will last for 16-weeks and includes 3-4 clinic visits and a series of weekly telephone calls from th...
What is the current status of trial NCT01170208?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2010-06. Estimated completion is 2011-03.
What interventions are being tested in trial NCT01170208?
The interventions under investigation include: insulin dose software (DEVICE).
Who is sponsoring clinical trial NCT01170208?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.